119 related articles for article (PubMed ID: 32971514)
1. Adjuvant Treatment of Early Ovarian Clear Cell Carcinoma: A Population-Based Study of Whole Abdominal Versus Pelvic Nodal Radiotherapy.
Roy S; Hoskins P; Tinker A; Brar H; Bowering G; Bahl G
J Natl Compr Canc Netw; 2020 Sep; 19(2):172-180. PubMed ID: 32971514
[TBL] [Abstract][Full Text] [Related]
2. The effect of adjuvant radiation on survival in early stage clear cell ovarian carcinoma.
Hogen L; Thomas G; Bernardini M; Bassiouny D; Brar H; Gien LT; Rosen B; Le L; Vicus D
Gynecol Oncol; 2016 Nov; 143(2):258-263. PubMed ID: 27623251
[TBL] [Abstract][Full Text] [Related]
3. Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort.
Prendergast EN; Holzapfel M; Mueller JJ; Leitao MM; Gunderson CC; Moore KN; Erickson BK; Leath CA; Diaz Moore ES; Cohen JG; Walsh CS
Gynecol Oncol; 2017 Feb; 144(2):274-278. PubMed ID: 27979319
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013.
Oseledchyk A; Leitao MM; Konner J; O'Cearbhaill RE; Zamarin D; Sonoda Y; Gardner GJ; Long Roche K; Aghajanian CA; Grisham RN; Brown CL; Snyder A; Chi DS; Soslow RA; Abu-Rustum NR; Zivanovic O
Ann Oncol; 2017 Dec; 28(12):2985-2993. PubMed ID: 28950307
[TBL] [Abstract][Full Text] [Related]
5. Utility of adjuvant whole abdominal radiation therapy in ovarian clear cell cancer (OCCC): a pragmatic cohort study of women with classic immuno-phenotypic signature.
Stevens MJ; West S; Gard G; Renaud C; Nevell D; Roderick S; Le A
Radiat Oncol; 2021 Feb; 16(1):29. PubMed ID: 33549120
[TBL] [Abstract][Full Text] [Related]
6. Impact of the number of cycles of platinum-based chemotherapy for early stage ovarian clear cell carcinoma on survival: a retrospective study.
Gao Y
BMC Womens Health; 2023 May; 23(1):262. PubMed ID: 37189098
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant taxane plus platinum chemotherapy for stage I ovarian clear cell carcinoma with complete surgical staging: are more than three cycles necessary?
Ukai M; Suzuki S; Yoshihara M; Yokoi A; Yoshikawa N; Kajiyama H; Kikkawa F
Int J Clin Oncol; 2022 Mar; 27(3):609-618. PubMed ID: 34779959
[TBL] [Abstract][Full Text] [Related]
8. Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation.
Hoskins PJ; Le N; Gilks B; Tinker A; Santos J; Wong F; Swenerton KD
J Clin Oncol; 2012 May; 30(14):1656-62. PubMed ID: 22493415
[TBL] [Abstract][Full Text] [Related]
9. The Significance of Radiotherapy in Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis.
Zhuang Y; Yang H
Cancer Control; 2023; 30():10732748231179291. PubMed ID: 37236911
[TBL] [Abstract][Full Text] [Related]
10. Effect of Chemotherapy, Laparoscopy, and Cytology on Stage IC Ovarian Clear Cell Carcinoma: A Long-Term, Single-Center Study.
Chang HT; Chiu ML; Wang TY; Chen TC; Chang CL; Su TH; Wang KG; Wang KL; Yang YC; Chen JR
Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31940991
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger PB; Ledermann JA; Khaw P; Colombo A; Fyles A; Baron MH; Jürgenliemk-Schulz IM; Kitchener HC; Nijman HW; Wilson G; Brooks S; Carinelli S; Provencher D; Hanzen C; Lutgens LCHW; Smit VTHBM; Singh N; Do V; D'Amico R; Nout RA; Feeney A; Verhoeven-Adema KW; Putter H; Creutzberg CL;
Lancet Oncol; 2018 Mar; 19(3):295-309. PubMed ID: 29449189
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy vs. observation in stage I clear cell ovarian carcinoma: A systematic review and meta-analysis.
Bogani G; Ditto A; Lopez S; Bertolina F; Murgia F; Pinelli C; Chiappa V; Raspagliesi F
Gynecol Oncol; 2020 Apr; 157(1):293-298. PubMed ID: 31980220
[TBL] [Abstract][Full Text] [Related]
13. Ovarian clear cell carcinoma, outcomes by stage: the MSK experience.
Shu CA; Zhou Q; Jotwani AR; Iasonos A; Leitao MM; Konner JA; Aghajanian CA
Gynecol Oncol; 2015 Nov; 139(2):236-41. PubMed ID: 26404183
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
Kuku S; Williams M; McCormack M
Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
[TBL] [Abstract][Full Text] [Related]
15. Survival Benefit of Adjuvant Radiotherapy: An Analysis of Low-Stage Invasive Ovarian Mucinous Carcinomas.
Kumar A; Le N; Gilks CB; Santos JL; Wong F; Swenerton K; Hoskins PJ; McAlpine JN; Tinker AV
Int J Gynecol Cancer; 2017 Nov; 27(9):1819-1825. PubMed ID: 28930809
[TBL] [Abstract][Full Text] [Related]
16. The role of adjuvant treatment for early-stage uterine clear cell carcinomas.
Orellana TJ; Garrett AA; Soong TR; Rives T; Courtney-Brooks M; Taylor SE; Lesnock J; Berger J; Boisen M; Coffman L; Buckanovich R; Mahdi H; Comerci JC; Beriwal S; Sukumvanich P; Edwards RP; Bhargava R; Olawaiye AB
Gynecol Oncol; 2023 Mar; 170():77-83. PubMed ID: 36641903
[TBL] [Abstract][Full Text] [Related]
17. Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion.
Matsuo K; Yoshino K; Hasegawa K; Murakami R; Ikeda Y; Adachi S; Hiramatsu K; Yokoyama T; Nishimura M; Sheridan TB; Enomoto T; Fujiwara K; Matsumura N; Konishi I; Fotopoulou C; Roman LD; Sood AK
Gynecol Oncol; 2015 Feb; 136(2):198-204. PubMed ID: 25497604
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience.
Armbruster SD; Previs R; Soliman PT; Westin SN; Fellman B; Jhingran A; Fleming ND
Gynecol Oncol; 2019 Aug; 154(2):328-332. PubMed ID: 31221496
[TBL] [Abstract][Full Text] [Related]
19. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
[TBL] [Abstract][Full Text] [Related]
20. Is adjuvant chemotherapy beneficial for surgical stage I ovarian clear cell carcinoma?
Hogen L; Brar H; Covens A; Bassiouny D; Bernardini MQ; Gien LT; Ferguson SE; Vicus D
Gynecol Oncol; 2017 Oct; 147(1):54-60. PubMed ID: 28760368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
